Wu, S., Deng, Y., Sun, H., Liu, X., Zhou, S., Zhao, H., . . . Lee, H. (2024). BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling. Signal Transduction and Targeted Therapy, 9(1), 1. https://doi.org/10.1038/s41392-024-02033-6
Chicago-referens (17:e uppl.)Wu, Shunkang, et al. "BRAF Inhibitors Enhance Erythropoiesis and Treat Anemia Through Paradoxical Activation of MAPK Signaling." Signal Transduction and Targeted Therapy 9, no. 1 (2024): 1. https://doi.org/10.1038/s41392-024-02033-6.
MLA-referens (9:e uppl.)Wu, Shunkang, et al. "BRAF Inhibitors Enhance Erythropoiesis and Treat Anemia Through Paradoxical Activation of MAPK Signaling." Signal Transduction and Targeted Therapy, vol. 9, no. 1, 2024, p. 1, https://doi.org/10.1038/s41392-024-02033-6.
